Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
???displayArticle.abstract???
Caenorhabditis elegans dauer formation is an alternative larval developmental pathway that the worm can take when environmental conditions become detrimental. Animals can survive several months in this stress-resistant stage and can resume normal development when growth conditions improve. Although the worms integrate a variety of sensory information to commit to dauer formation, it is currently unknown whether they also monitor internal cellular damage. The Ro ribonucleoprotein complex, which was initially described as a human autoantigen, is composed of one major 60-kDa protein, Ro60, that binds to one of four small RNA molecules, designated Y RNAs. Ro60 has been shown to bind mutant 5S rRNA molecules in Xenopus oocytes, suggesting a role for Ro60 in 5S rRNA biogenesis. Analysis of ribosomes from a C. elegans rop-1(-) strain, which is null for the expression of Ro60, demonstrated that they contain a high percentage of mutant 5S rRNA molecules, thereby strengthening the notion of a link between the rop-1 gene product and 5S rRNA quality control. The Ro particle was recently shown to be involved in the resistance of Deinococcus radiodurans to UV irradiation, suggesting a role for the Ro complex in stress resistance. We have studied the role of rop-1 in dauer formation. We present genetic and biochemical evidence that rop-1 interacts with dauer-formation genes and is involved in the regulation of the worms' entry into the dauer stage. Furthermore, we find that the rop-1 gene product undergoes a proteolytic processing step that is regulated by the dauer formation pathway via an aspartic proteinase. These results suggest that the Ro particle may function in an RNA quality-control checkpoint for dauer formation.
Ailion,
Neurosecretory control of aging in Caenorhabditis elegans.
1999, Pubmed
Ailion,
Neurosecretory control of aging in Caenorhabditis elegans.
1999,
Pubmed
Alspaugh,
Antibodies to cellular antigens in Sjögren's syndrome.
1975,
Pubmed
Antebi,
daf-12 encodes a nuclear receptor that regulates the dauer diapause and developmental age in C. elegans.
2000,
Pubmed
Baker,
Role of insulin-like growth factors in embryonic and postnatal growth.
1993,
Pubmed
Bernstein,
Crystal structure of the novel aspartic proteinase zymogen proplasmepsin II from plasmodium falciparum.
1999,
Pubmed
Birnby,
A transmembrane guanylyl cyclase (DAF-11) and Hsp90 (DAF-21) regulate a common set of chemosensory behaviors in caenorhabditis elegans.
2000,
Pubmed
Bosher,
RNA interference: genetic wand and genetic watchdog.
2000,
Pubmed
Brenner,
The genetics of Caenorhabditis elegans.
1974,
Pubmed
Brunet,
Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor.
1999,
Pubmed
Cassada,
The dauerlarva, a post-embryonic developmental variant of the nematode Caenorhabditis elegans.
1975,
Pubmed
Chen,
Ro ribonucleoproteins contribute to the resistance of Deinococcus radiodurans to ultraviolet irradiation.
2000,
Pubmed
Clark,
Characterization of a soluble cytoplasmic antigen reactive with sera from patients with systemic lupus erythmatosus.
1969,
Pubmed
Fire,
Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans.
1998,
Pubmed
Gems,
Two pleiotropic classes of daf-2 mutation affect larval arrest, adult behavior, reproduction and longevity in Caenorhabditis elegans.
1998,
Pubmed
Gil,
Regulation of the insulin-like developmental pathway of Caenorhabditis elegans by a homolog of the PTEN tumor suppressor gene.
1999,
Pubmed
Golden,
The Caenorhabditis elegans dauer larva: developmental effects of pheromone, food, and temperature.
1984,
Pubmed
Hobert,
Regulation of interneuron function in the C. elegans thermoregulatory pathway by the ttx-3 LIM homeobox gene.
1997,
Pubmed
Kelly,
Distinct requirements for somatic and germline expression of a generally expressed Caernorhabditis elegans gene.
1997,
Pubmed
Kenyon,
A C. elegans mutant that lives twice as long as wild type.
1993,
Pubmed
Kimura,
daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans.
1997,
Pubmed
Kops,
Direct control of the Forkhead transcription factor AFX by protein kinase B.
1999,
Pubmed
Labbé,
The levels of the RoRNP-associated Y RNA are dependent upon the presence of ROP-1, the Caenorhabditis elegans Ro60 protein.
1999,
Pubmed
Labbé,
Assessing the function of the Ro ribonucleoprotein complex using Caenorhabditis elegans as a biological tool.
1999,
Pubmed
,
Xenbase
Labbé,
The Caenorhabditis elegans rop-1 gene encodes the homologue of the human 60-kDa Ro autoantigen.
1995,
Pubmed
Larsen,
Genes that regulate both development and longevity in Caenorhabditis elegans.
1995,
Pubmed
Lewis,
Basic culture methods.
1995,
Pubmed
Lin,
daf-16: An HNF-3/forkhead family member that can function to double the life-span of Caenorhabditis elegans.
1997,
Pubmed
Mattioli,
Heterogeneity of RNA protein antigens reactive with sera of patients with systemic lupus erythematosus. Description of a cytoplasmic nonribosomal antigen.
1974,
Pubmed
Mello,
DNA transformation.
1995,
Pubmed
Mihaylova,
The PTEN tumor suppressor homolog in Caenorhabditis elegans regulates longevity and dauer formation in an insulin receptor-like signaling pathway.
1999,
Pubmed
Morris,
A phosphatidylinositol-3-OH kinase family member regulating longevity and diapause in Caenorhabditis elegans.
1996,
Pubmed
Nakae,
Insulin stimulates phosphorylation of the forkhead transcription factor FKHR on serine 253 through a Wortmannin-sensitive pathway.
1999,
Pubmed
O'Brien,
A possible role for the 60-kD Ro autoantigen in a discard pathway for defective 5S rRNA precursors.
1994,
Pubmed
,
Xenbase
Ogg,
The C. elegans PTEN homolog, DAF-18, acts in the insulin receptor-like metabolic signaling pathway.
1998,
Pubmed
Ogg,
The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans.
1997,
Pubmed
Paradis,
Caenorhabditis elegans Akt/PKB transduces insulin receptor-like signals from AGE-1 PI3 kinase to the DAF-16 transcription factor.
1998,
Pubmed
Pellizzoni,
Involvement of the Xenopus laevis Ro60 autoantigen in the alternative interaction of La and CNBP proteins with the 5'UTR of L4 ribosomal protein mRNA.
1998,
Pubmed
,
Xenbase
Powell-Braxton,
IGF-I is required for normal embryonic growth in mice.
1993,
Pubmed
Ren,
Control of C. elegans larval development by neuronal expression of a TGF-beta homolog.
1996,
Pubmed
Rouault,
Regulation of dauer larva development in Caenorhabditis elegans by daf-18, a homologue of the tumour suppressor PTEN.
1999,
Pubmed
Shi,
A misfolded form of 5S rRNA is complexed with the Ro and La autoantigens.
1996,
Pubmed
,
Xenbase
Thomas,
Evidence for parallel processing of sensory information controlling dauer formation in Caenorhabditis elegans.
1993,
Pubmed
Tumminello,
Pepstatins: aspartic proteinase inhibitors having potential therapeutic applications.
1993,
Pubmed
Wadsworth,
Acidic intracellular pH shift during Caenorhabditis elegans larval development.
1988,
Pubmed
